deltatrials
Unknown PHASE4 INTERVENTIONAL 2-arm NCT03096613

Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)

Efficacy and Safety of Levothyroxine (L-T4) Replacement on Exercise Capability in Chronic Systolic Heart Failure Patients With Subclinical Hypothyroidism: A 24-week, Multi-center, Open Label, Randomized, Parallel Group Trial

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital

Interventions Levothyroxine
Updated 8 times since 2017 Last updated: Mar 28, 2018 Started: Apr 18, 2017 Primary completion: Feb 28, 2019 Completion: Feb 28, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Heart Failure and Subclinical Hypothyroidism, this trial is ongoing. The trial is conducted by Chinese Academy of Medical Sciences, Fuwai Hospital and has accumulated 8 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Apr 2017 – ~Mar 2018 · 11 months · monthly snapshotRecruiting~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshotRecruiting~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotRecruiting~Jun 2018 – ~Apr 2020 · 22 months · monthly snapshotRecruiting~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 23 months · monthly snapshotUnknown

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  4. Apr 2020 — Jan 2021 [monthly]

    Unknown Status PHASE4

    Status: RecruitingUnknown Status

  5. Jun 2018 — Apr 2020 [monthly]

    Recruiting PHASE4

Show 3 earlier versions
  1. Apr 2018 — Jun 2018 [monthly]

    Recruiting PHASE4

  2. Mar 2018 — Apr 2018 [monthly]

    Recruiting PHASE4

  3. Apr 2017 — Mar 2018 [monthly]

    Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chinese Academy of Medical Sciences, Fuwai Hospital
  • Henan Provincial People's Hospital
  • The First Hospital of Hebei Medical University
  • The Luhe Teaching Hospital of the Capital Medical University
  • Tianjin Medical University Second Hospital
Data source: Chinese Academy of Medical Sciences, Fuwai Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations